Bupropion Hydrochloride
- Product NDC
- 70934-929
- 11-digit product format
- 709340929
- Labeler code
- 70934
- Product ID
- 70934-929_f161544b-40d8-6c22-e053-2995a90ad846
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA090693
- Marketing category
- ANDA
- Marketing start
- 2021-12-02
- Marketing end
- 2023-01-31
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| ZG7E5POY8O | BUPROPION HYDROCHLORIDE | 31677-93-7 | BUPROPION HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-929-90 | 70934092990 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-929-90) | 2021-12-02 | 0000-00-00 | No | No | Current |